INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
Scope & Guideline
Innovating insights in molecular biology and genetics.
Introduction
Aims and Scopes
- Molecular Mechanisms of Disease:
The journal frequently publishes studies elucidating the molecular underpinnings of various diseases, including cancer, diabetes, cardiovascular disorders, and neurodegenerative diseases. This includes research on gene expression, signaling pathways, and cellular responses. - Therapeutic Strategies and Drug Development:
A significant focus is placed on novel therapeutic strategies and drug development, particularly in cancer therapy and regenerative medicine. This encompasses studies on small molecules, biologics, and advanced therapies such as gene editing and stem cell applications. - Role of Non-Coding RNAs and Epigenetics:
The journal showcases research on the regulatory roles of non-coding RNAs, including microRNAs and long non-coding RNAs, in gene expression and their implications in disease processes and therapy. - Immunology and Inflammation:
Studies related to the immune system, inflammatory responses, and their implications in diseases such as autoimmune disorders and cancer are prominent, highlighting the intersection of molecular medicine and immunology. - Translational Research:
The journal emphasizes translational research that connects laboratory findings with clinical applications, aiming to enhance understanding and treatment of diseases through innovative approaches. - Emerging Technologies:
The integration of novel technologies, including CRISPR, nanomedicine, and advanced imaging techniques, is a recurring theme, reflecting the journal's commitment to cutting-edge scientific advancements.
Trending and Emerging
- Role of Microbiome in Health and Disease:
Research on the human microbiome and its influence on health and disease is gaining momentum, particularly in relation to metabolic disorders, autoimmune diseases, and cancer. - Ferroptosis and Regulated Cell Death:
The exploration of ferroptosis and other forms of regulated cell death is becoming increasingly prominent, particularly in the context of cancer and neurodegenerative diseases, as researchers seek to understand and manipulate these pathways for therapeutic benefit. - Advanced Biomaterials and Regenerative Medicine:
There is a growing interest in the development of innovative biomaterials and their applications in regenerative medicine, including tissue engineering and wound healing. - Gene Editing and CRISPR Technologies:
The application of CRISPR and other gene-editing technologies is emerging as a significant area of research, with studies exploring their potential in treating genetic disorders and cancer. - Immunotherapy Innovations:
Immunological approaches, particularly novel immunotherapies for cancer and autoimmune disorders, are trending, with increased focus on understanding immune checkpoints and developing combination therapies. - Personalized Medicine and Genomic Approaches:
The journal is increasingly publishing research that focuses on personalized medicine, utilizing genomic data to tailor treatments to individual patients based on their unique genetic and molecular profiles.
Declining or Waning
- Traditional Pharmacology and Single-Agent Studies:
There has been a noticeable decline in studies focused solely on traditional pharmacological approaches and single-agent therapies, as the field increasingly moves towards combination therapies and personalized medicine. - Basic Mechanistic Studies Without Clinical Relevance:
Papers that focus exclusively on basic mechanistic insights without clear clinical implications or translational potential are appearing less frequently as the journal prioritizes research that bridges basic science with clinical applications. - Animal Models of Disease:
Research relying heavily on conventional animal models without addressing translational relevance is declining, as there is a growing emphasis on humanized models or more sophisticated in vitro systems that better mimic human pathophysiology. - Static Disease Models:
Studies employing static models of disease that do not incorporate dynamic or multi-faceted approaches are less common, as researchers favor more comprehensive systems that reflect the complexities of human diseases.
Similar Journals
BIOFACTORS
Advancing the Frontiers of Biochemistry and Molecular MedicineBIOFACTORS, an esteemed journal published by Wiley, serves as a pivotal resource in the fields of Biochemistry, Clinical Biochemistry, and Molecular Medicine. With ISSN 0951-6433 and E-ISSN 1872-8081, the journal has established its reputation since its inception in 1988, showcasing a rich history of scientific inquiry and innovation. Recognized for its high academic standards, it currently holds a Q1 ranking in key categories, including Biochemistry and Medicine (miscellaneous), and ranks in the top 10% for Clinical Biochemistry according to Scopus metrics, reflecting its impact and influence in the scientific community. Although it does not offer Open Access, BIOFACTORS provides researchers the opportunity to publish and disseminate high-quality studies that advance our understanding of biological factors and their clinical implications. The journal actively encourages contributions that bridge the gap between laboratory findings and clinical applications, making it a vital platform for both seasoned researchers and emerging scholars in the life sciences.
JOURNAL OF MOLECULAR MEDICINE-JMM
Elevating the Standards of Molecular Medicine Research.JOURNAL OF MOLECULAR MEDICINE (JMM) is a premier publication dedicated to advancing the field of molecular medicine, encompassing critical areas such as drug discovery, genetics, and biochemistry. Published by Springer Heidelberg in Germany, this influential journal has established its significance within the academic community, achieving an impressive Q1 ranking across multiple categories as of 2023, including Drug Discovery, Clinical Genetics, and Molecular Medicine. With a focus on publishing high-quality research and novel insights, JMM appeals to a diverse audience of researchers, professionals, and students passionate about the molecular underpinnings of health and disease. The journal, which has seen a convergence of relevant research spanning from 1976 to 2024, is instrumental in showcasing groundbreaking studies that push the boundaries of knowledge in molecular therapeutics and biomedical science. While it does not offer open access, the rigor of its peer-reviewed content ensures that each publication is a valuable addition to the scientific discourse surrounding molecular medicine. For comprehensive studies and reviews that highlight the intersection of molecular biology and clinical application, look no further than JOURNAL OF MOLECULAR MEDICINE.
ACTA BIOCHIMICA POLONICA
Shaping the Future of Biochemistry with Every PublicationACTA BIOCHIMICA POLONICA (ISSN: 0001-527X, E-ISSN: 1734-154X) is a distinguished journal published by the ACTA BIOCHIMICA POLONICA in Poland, with a rich history dating back to 1955. As a prominent platform for disseminating research, it currently holds a Category Quartile of Q3 in the fields of Biochemistry, Genetics, and Molecular Biology, reflecting its commitment to advancing knowledge in these critical areas. This journal is indexed in Scopus, ranking 124 out of 221, placing it in the 44th percentile among general biochemistry, genetics, and molecular biology journals. Although it does not operate under an open-access model, ACTA BIOCHIMICA POLONICA remains a vital resource for researchers, professionals, and students seeking to delve into the latest developments and discoveries in biochemistry and molecular biology. Its strategic focus on contemporary topics ensures that it plays an essential role in shaping future scientific inquiries and fostering collaboration across various disciplines.
CELL CYCLE
Charting New Territories in Cell Cycle Understanding.CELL CYCLE, an esteemed journal published by Taylor & Francis Inc., stands at the forefront of biological research, focusing on the intricate mechanisms of cell proliferation, molecular biology, and developmental biology. With an ISSN of 1538-4101 and an E-ISSN of 1551-4005, this journal has established its influence in the field with a commendable impact factor reflecting its rigorous peer-review process and high-quality publications. Notably, in 2023, it achieved a Q1 ranking in Medicine (miscellaneous) and a Q2 ranking in both Cell Biology and Developmental Biology, marking its vital role in advancing scientific understanding and innovation. Operating within a converged framework from 2002 to 2024, CELL CYCLE caters to a diverse audience of researchers, professionals, and students eager to explore contemporary findings and emerging trends. The journal's objective is to disseminate groundbreaking research that enhances our understanding of cellular mechanisms, fostering collaboration and innovation. Although not an open-access journal, it remains a premier source for those engaged in cell cycle research, and its contributions have significant implications for fields such as healthcare, biotechnology, and genetics.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
Illuminating the Pathways of Molecular MedicineNUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS is a vital academic journal published by Taylor & Francis Inc, dedicated to the intricate and evolving domains of biochemistry, genetics, and molecular medicine. With an ISSN of 1525-7770 and E-ISSN of 1532-2335, this journal aims to provide a comprehensive platform for the dissemination of research findings, reviews, and methodologies related to nucleosides, nucleotides, and nucleic acids. As a research journal thriving since its inception in 2000, it reflects a diverse spectrum of studies crucial for advancing knowledge in biochemistry (ranked Q4) and genetics (Q4), while also achieving Q3 status in medicine (miscellaneous). Despite its current standing in the quartiles and Scopus rankings indicative of an emergent trajectory, the journal retains significant relevance for those delving into interdisciplinary research that intersects these fields. Researchers, professionals, and students alike can explore a plethora of original research articles, thought-provoking reviews, and updates on pioneering advances that shape our understanding of molecular biology. With its unwavering commitment to scholarly excellence, NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS continues to be an essential resource for those aiming to contribute to and stay informed about this pivotal area of scientific inquiry.
Non-Coding RNA
Empowering Researchers with Open Access to RNA ScienceNon-Coding RNA is a prestigious open-access journal published by MDPI, based in Switzerland, dedicated to the significant and rapidly evolving field of non-coding RNA research. Established in 2015, this journal has quickly become an essential resource for researchers and professionals, showcasing innovative studies and breakthroughs related to the functions and mechanisms of non-coding RNAs in various biological processes. With an impressive Q1 ranking in Biochemistry and strong rankings in Genetics and Molecular Biology, Non-Coding RNA consistently reflects the highest standards of academic publishing. The journal provides comprehensive access options, granting researchers worldwide the ability to disseminate and access high-quality research without subscription barriers. As the landscape of genomics and molecular discoveries continues to expand, the journal aims to foster interdisciplinary exchanges and collaborations, making it a vital platform for advancing knowledge and innovation in this critical area of biological science.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
Unleashing Innovations in Physiology and BiochemistryCellular Physiology and Biochemistry is a premier Open Access journal published by the prestigious Cell Physiol Biochem Press GmbH & Co, dedicated to advancing research in the fields of physiology, biochemistry, and molecular biology. Since its inception in 1987 and transitioning to an Open Access model in 2013, the journal has established itself as a vital resource for the dissemination of high-quality research and reviews, showcasing innovative methodologies and groundbreaking findings in cellular processes. With an impressive ranking in the 2023 Scopus category as Q2 in Physiology and a robust percentile of 61, Cellular Physiology and Biochemistry is committed to fostering academic dialogue among researchers, professionals, and students alike. This journal not only provides unrestricted access to its articles, but also promotes the global sharing of knowledge, which is essential for the advancement of our understanding in these vital scientific areas. The journal's editorial team is dedicated to ensuring the highest standards of academic rigor and relevance, making it an indispensable addition to the libraries of those engaged in the life sciences.
RNA
Advancing the Frontiers of RNA ResearchRNA is a premier journal in the field of molecular biology, published by COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT. With an impressive impact factor reflected by its Q1 status in the Molecular Biology category, this journal has established itself as an essential resource for researchers and professionals dedicated to understanding the role of RNA in biological processes. Spanning over two decades of impactful research from 1995 to 2024, RNA covers a broad spectrum of topics, including RNA biology, gene regulation, and therapeutic innovations. Researchers can access its extensive array of original research articles, reviews, and commentary, making it a vital conduit for new discoveries and methodologies in the field. With its high ranking within Scopus at Rank #115/410 and a 72nd percentile ranking in the domain of Biochemistry, Genetics, and Molecular Biology, RNA continues to advance the understanding of RNA and its critical contributions to life sciences.
MOLECULAR MEDICINE
Empowering Research through Open Access InsightsMOLECULAR MEDICINE, published by SPRINGER, is a leading scholarly journal dedicated to advancing the fields of genetics and molecular biology with a focus on clinical applications. Since its inception in 1994, it has evolved to become a pivotal platform for disseminating innovative research findings, achieving a remarkable Q1 ranking in multiple categories, including Genetics, Molecular Biology, and Molecular Medicine as of 2023. Featuring an Open Access model since 2000, the journal ensures that cutting-edge research is freely available to the global scientific community, facilitating collaboration and knowledge exchange. With a commitment to high-quality peer-reviewed content, MOLECULAR MEDICINE serves as an essential resource for researchers, healthcare professionals, and students seeking to stay at the forefront of molecular research and its implications for medical science. For those interested in contributing to or accessing vital research in this dynamic field, MOLECULAR MEDICINE stands out as a premier choice.
CELLULAR & MOLECULAR BIOLOGY LETTERS
Bridging Gaps in Cellular Research for a Global AudienceCELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.